# William Tong

Type: Person

Source: GetYourBrief — https://getyourbrief.com/entity/william-tong
Canonical HTML page: https://getyourbrief.com/entity/william-tong

## Recent coverage (4 stories, network-wide)

### Dozens of federal probes scrapped as state AGs tackle price-gouging
2026-07-31 21:58:22 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Persistently high consumer prices and the void left by the CFPB’s dismantling are driving state AGs to launch multi-state actions against alleged price fixing and deceptive practices. For investors and markets, the resulting patchwork of state-level regulations introduces new compliance costs and legal uncertainties across sectors.
Full story: https://getfinancebrief.com/story/state-ags-price-gouging-enforcement-cfpb

### State AGs absorb dozens of dropped CFPB cases as federal enforcement retreats
2026-07-31 21:57:14 · Sector: legal · Sentiment: Neutral · Impact: 6/10 · Sources: 2

With the CFPB gutted and dozens of investigations abandoned, state attorneys general are leveraging state UDAP laws and federal antitrust statutes to fill the enforcement void. Bipartisan coalitions are forming, creating a fragmented but active regulatory landscape that challenges traditional federal preemption models.
Full story: https://getlegalbrief.com/story/state-ags-cfpb-consumer-enforcement-shift

### CVS’s $36.5M insulin billing settlement rattles retail pharmacy trust
2026-07-11 00:03:06 · Sector: retail · Sentiment: Neutral · Impact: 6/10 · Sources: 1

CVS Health’s $36.5 million settlement over Medicaid overbilling for insulin pens threatens to erode consumer confidence in its retail pharmacy operations. The decade-long scheme of excessive refills raises questions about pharmacy integrity and could prompt operational overhauls that reshape the competitive landscape.
Full story: https://getretailbrief.com/story/cvs-36-5m-medicaid-settlement-retail-impact

### CVS’s $36.5M insulin settlement: pockets of risk for investors
2026-07-11 00:03:01 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 1

CVS Health’s $36.5 million payout to settle Medicaid billing allegations is financially immaterial but signals deepening regulatory scrutiny. Investors must weigh the settlement as part of a pattern of compliance issues that could escalate into larger liabilities, audit costs, and potential litigation.
Full story: https://getfinancebrief.com/story/cvs-36-5m-settlement-financial-regulation-risk

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.